EZDriveMA Smishing Scam
Got a text about unpaid tolls? Here’s what you need to know.
Ozempic, Wegovy, and Other GLP-1 RA Medications
Multiple class-action lawsuits regarding the marketing of GLP-1 RAs were transferred to be heard together as part of multidistrict litigation (MDL). More information on the MDL is below.
Case Name (Date)
In Re: Glucagon-Like Peptide-1 Receptor Agonists (GLP-1 RAs) Products Liability Litigation
24-md-3094, E.D. Penn.
(2024)
Product/Service
Ozempic, Wegovy, Rybelsus, Saxenda, Victoza, Mounjaro, Zepbound, Trulicity and other GLP-1 RA medications
Allegations
Marketing products as weight-loss medications without adequately disclosing that many people stop using them due to their side effects, the medications do not result in meaningful weight loss for up to 15 percent of people, the average weight loss is approximately 10 percent of a person’s body weight, and people need to stay on them to maintain their weight loss
Status
Pending
The Latest
NCPW 2025: Fighting against Deceptive Marketing
If you’ve been misled by an ad, regulators want to hear from you. We do too.
Xfinity Home Internet and Mobile Promotion
It’s easier to rack up hidden fees than it is to cancel.
AARP Membership
The only thing more “ridiculous” than the touted benefits is the cancellation process.
Should Movie Theaters Be Required to Advertise Actual Start Times?
Under a proposed bill, theaters could be fined for making moviegoers guess.